Results 171 to 180 of about 14,564 (189)

A preclinical and clinical review of aflibercept for the management of cancer

Cancer Treatment Reviews, 2012
Andrew Gaya
exaly  

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology, 2016
Gunnar Folprecht, C Pericay, M P Saunders   +2 more
exaly  

A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously

Analytical and Bioanalytical Chemistry, 2020
Fangjie Liu, Wanhui Liu, Fei Yu
exaly  

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic Oncology, 2012
Robert L Coleman, Heather A Lankes, D Scott Mcmeekin   +2 more
exaly  

Aflibercept: A Review in Metastatic Colorectal Cancer

Drugs, 2015
Yahiya Y Syed, Kate Mckeage, Syed Yahiya Y   +2 more
exaly  

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

European Journal of Cancer, 2014
Josep Tabernero, Paul Ruff, Vladimir M Moiseyenko   +2 more
exaly  

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

European Journal of Cancer, 2013
Philippe Rougier, Yves Humblet, Carlo Barone   +2 more
exaly  

The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice

Acta Pharmacologica Sinica, 2020
Ming-Ming Wu, Hui-Hua Li, Bo Zhang
exaly  

Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology, 2018
Emine Alyamac Sukgen, Yusuf Koçluk, Koçluk Yusuf   +2 more
exaly  

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway

Biochemical Pharmacology, 2019
Annamaria Fidilio, Chiara Bianca Maria Platania, Giovanni Giurdanella   +2 more
exaly